How oncologists respond to negative trials
FDA Withdrawals and Oncology Drug Use The U.S. Food and Drug Administration’s (FDA) accelerated approval…
Browsing: Featured
EAU 2025: Sensory t-shirt collects patient data and enables shorter postoperative hospital stay
A t-shirt that monitors a patient’s vitals after urological surgery for cancer could help people…
Building the AI-enabled medical school of the future: A new era in clinician education?
In a viewpoint letter published in JAMA on 31 March 2025, Marc D. Succi, Bernard…
Citrus remedy squeezes out dry mouth for cancer patients
A natural citrus oil from oranges, lemons, and limes is proving highly effective in relieving…
Earliest stages and possible new cause of stomach cancer revealed
For the first time, scientists have systematically analysed somatic mutations in stomach lining tissue to…
Uniquely shaped, fast-heating nanoparticles halt ovarian tumour growth
New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a…
High levels of traumatic stress found in caregivers of adult cancer patients
Every year, millions of family members and friends provide care for loved ones undergoing cancer…
The secret DNA circles fueling pancreatic cancer’s aggression
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of…
Is red wine a healthier choice than white wine? Uncorking the cancer risks
A common perception is that not all alcoholic beverages are alike. Red wine, for instance,…
S3E2 The Oncology Journal Club: Is DEI Dead? The Future of Diversity, Equity and Inclusion in Healthcare
Welcome to Episode 2 of the third series of The Oncology Journal Club. Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to digest how political changes in the US will have a wider impact on oncology care and research globally.